Back to Search
Start Over
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
- Source :
- JHEP Reports, JHEP Reports, Vol 3, Iss 6, Pp 100356-(2021)
- Publication Year :
- 2021
-
Abstract
- Background & Aims Currently available HDV PCR assays are characterized by considerable run-to-run and inter-laboratory variability. Hence, we established a quantitative reverse transcription real-time PCR (RT-qPCR) assay on the open channel of a fully automated PCR platform (cobas6800, Roche) offering improved consistency and reliability. Methods A primer/probe-set targeting a highly conserved region upstream of the HDV antigen was adapted for use on the cobas6800. The lower limit of detection (LLOD) was determined using a dilution panel of the HDV WHO standard (n = 21/dilution). Linearity and inclusivity were tested by preparing 10-fold dilution series of cell culture-derived virus (genotype [GT]1-8; n = 5/dilution). Patient samples containing a variety of bloodborne viral pathogens were tested to confirm exclusivity (n = 60). Results The LLOD of the HDV utility-channel (HDV_UTC) assay was determined as 3.86 IU/ml (95% CI 2.95–5.05 IU/ml) with a linear range from 10–10ˆ8 IU/ml (GT1). Linear relationships were observed for all HDV GTs with slopes ranging from -3.481 to -4.134 cycles/log and R2 from 0.918 to 0.994. Inter-run and intra-run variability were 0.3 and 0.6 Ct (3xLLOD), respectively. No false-positive results were observed. To evaluate clinical performance, 110 serum samples of anti-HDV-Ab+ patients were analyzed using the HDV_UTC and CE-IVD RoboGene assays. 58/110 and 49/110 samples were concordant positive or negative, respectively (overall agreement 97.3%). Quantitative comparison demonstrated a strong correlation (R2 0.8733; 95% CI 0.8914–0.9609; p value<br />Highlights • Establishment and validation of new quantitative HDV PCR assay on a fully automated platform (cobas6800). • New assay allows for dynamic scaling of testing capacity and drastically reduces hands-on time as wells as manual steps. • Improved reliability and reproducibility of test results. • Lower limit of quantification of 10 IU/ml and a linear range from 101–108 IU/ml. • Inclusivity for all 8 known HDV genotypes.<br />Graphical abstract
- Subjects :
- HDV, Hepatitis delta virus
EQA, external quality assessment
viruses
Short Communication
cHDV, chronic HDV infection
viral hepatitis
RC799-869
RT-qPCR, Real time reverse transcription polymerase chain reaction
Biology
law.invention
molecular diagnostics
LLOD, lower limit of detection
law
External quality assessment
Genotype
Internal Medicine
medicine
Immunology and Allergy
Polymerase chain reaction
Detection limit
Reproducibility
HDV_UCT, HDV utility-channel
cobas6800
Hepatology
Gastroenterology
Diseases of the digestive system. Gastroenterology
Molecular diagnostics
medicine.disease
Virology
quantification
RT-qPCR, reverse transcription quantitative real-time PCR
WHO, world health organization
Viral hepatitis
Viral load
GT, genotypes
CE-IVD, CE-marked in vitro diagnostics
Subjects
Details
- ISSN :
- 25895559
- Volume :
- 3
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- JHEP reports : innovation in hepatology
- Accession number :
- edsair.doi.dedup.....a5e839701df52b68dd15dad8d579025f